Initially described as elevated among other markers of endotheliopathy and glycocalyx damage [[26], [27], [28]], von Willebrand factor (VWF) seems to even more accurately predict outcomes, especially mortality, in patients with COVID-19 [21,22,[29], [30], [31], [32], [33]]. The gene discussed is VWF; the disease is COVID-19.